Cargando…

Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report

INTRODUCTION: The appearance of anti-insulin antibodies or an allergy to insulin occasionally causes clinical problems with glycemic control in insulin users. METHODS: In the present report, we describe a therapeutic approach that was employed for a man with type 2 diabetes who had insulin allergy,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumoto, Yuko, Yamada, Hodaka, Funazaki, Shunsuke, Suzuki, Daisuke, Kakei, Masafumi, Hara, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630548/ https://www.ncbi.nlm.nih.gov/pubmed/28836180 http://dx.doi.org/10.1007/s13300-017-0291-2

Ejemplares similares

Diabetic ketoacidosis producing extreme hyperkalemia in a patient with type 1 diabetes on hemodialysis
por: Yamada, Hodaka, et al.
Publicado: (2017)

Background Factors Determining the Introduction and Dosage of Insulin in Women With Gestational Diabetes Mellitus
por: Matsumoto, Yuko, et al.
Publicado: (2019)

A novel mechanism of imeglimin‐mediated insulin secretion via the cADPR‐TRP channel pathway
por: Funazaki, Shunsuke, et al.
Publicado: (2021)

Association between Urinary Calcium Excretion and Estimated Glomerular Filtration Rate Decline in Patients with Type 2 Diabetes Mellitus: A Retrospective Single-center Observational Study
por: Yamada, Hodaka, et al.
Publicado: (2018)

The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio, Deemed the Nephron Index, Is a Useful Clinical Index for Early Stage Chronic Kidney Disease in Patients with Type 2 Diabetes: An Observational Pilot Study
por: Yamada, Hodaka, et al.
Publicado: (2018)

Effects of Repaglinide Versus Glimepiride on 1,5-Anhydroglucutol and Glycated Hemoglobin Levels in Japanese Patients With Type 2 Diabetes
por: Yamada, Hodaka, et al.
Publicado: (2018)

Sodium–glucose cotransporter 2 inhibitors improved time‐in‐range without increasing hypoglycemia in Japanese patients with type 1 diabetes: A retrospective, single‐center, pilot study
por: Suzuki, Daisuke, et al.
Publicado: (2020)

Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study
por: Yamada, Hodaka, et al.
Publicado: (2022)

Correction: Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study
por: Yamada, Hodaka, et al.
Publicado: (2023)

Pseudo Intestinal Obstruction Caused by Malignant Paraganglioma
por: Funazaki, Shunsuke, et al.
Publicado: (2021)

Risk Factors of Hypoglycemic Encephalopathy and Prolonged Hypoglycemia in Patients With Severe Hypoglycemia
por: Saikawa, Rika, et al.
Publicado: (2019)

Spontaneous pregnancy after full recovery from hypopituitarism caused by lymphocytic hypophysitis
por: Funazaki, Shunsuke, et al.
Publicado: (2018)

Retrospective Study of IDegLira, a New Fixed-Ratio Combination, in Japanese Patients With Type 2 Diabetes Mellitus: Analysis of Background Factors Affecting Effectiveness After 6 Months of Treatment
por: Yamada, Hodaka, et al.
Publicado: (2023)

The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report
por: Hirai, Hiroyuki, et al.
Publicado: (2016)

Retrospective Analysis of the Effectiveness of Oral Semaglutide in Type 2 Diabetes Mellitus and Its Effect on Cardiometabolic Parameters in Japanese Clinical Settings
por: Yamada, Hodaka, et al.
Publicado: (2023)

Efficacy and safety of liraglutide added to insulin therapy in elderly patients with type 2 diabetes
por: Tonoike, Mie, et al.
Publicado: (2018)

Successful control of a case of severe insulin allergy with liraglutide
por: Kawanami, Daiji, et al.
Publicado: (2013)

Effects of liraglutide on postprandial insulin and glucagon responses in Japanese patients with type 2 diabetes
por: Matsumoto, Shinobu, et al.
Publicado: (2013)

Case of fulminant type 1 diabetes with coronary microcirculatory dysfunction
por: Yamada, Hodaka, et al.
Publicado: (2014)

Insulin degludec/liraglutide (IDegLira) for the treatment of type 2 diabetes
por: Gough, Stephen CL, et al.
Publicado: (2016)

The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis
por: Zhang, Jiudan, et al.
Publicado: (2021)

Managing insulin resistance: role of liraglutide
por: Kalra, Sanjay, et al.
Publicado: (2010)

Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
por: Minze, Molly G, et al.
Publicado: (2016)

Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus
por: Mader, Julia K., et al.
Publicado: (2016)

Retrospective Analysis of an Insulin-to-Liraglutide Switch in Patients with Type 2 Diabetes Mellitus
por: Bruinstroop, Eveline, et al.
Publicado: (2018)

Spontaneous recovery of immune checkpoint inhibitor‐induced thyroiditis with high free T4 level: A case report
por: Hagiwara, Rie, et al.
Publicado: (2021)

Is a Switch From Insulin Therapy to Liraglutide Possible in Japanese Type 2 Diabetes Mellitus Patients?
por: Kawata, Takehiro, et al.
Publicado: (2014)

Potentiation of Glucose-stimulated Insulin Secretion by the GPR40–PLC–TRPC Pathway in Pancreatic β-Cells
por: Yamada, Hodaka, et al.
Publicado: (2016)

Liraglutide Treatment in a Patient With HIV and Uncontrolled Insulin-Treated Type 2 Diabetes
por: Diamant, Michaela, et al.
Publicado: (2012)

Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin‐secreting capacity
por: Kozawa, Junji, et al.
Publicado: (2012)

Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)
por: Lind, Marcus, et al.
Publicado: (2015)

Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes
por: Ericsson, Åsa, et al.
Publicado: (2018)

Relationship Between Angiopoietin-Like Protein 8 and Fasting Serum Triglyceride Level
por: Yamada, Hodaka, et al.
Publicado: (2018)

Serious diabetic ketoacidosis induced by insulin allergy and anti‐insulin antibody in an individual with type 2 diabetes mellitus
por: Takahashi, Kaio, et al.
Publicado: (2022)

Hypereosinophilia is a predictive biomarker of immune checkpoint inhibitor-induced hypopituitarism in patients with renal cell carcinoma
por: Yamada, Hodaka, et al.
Publicado: (2022)

A case of insulin allergy in a girl with type 1 diabetes
por: Moelyo, Annang Giri, et al.
Publicado: (2013)

Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese patients with type 2 diabetes in a phase 3, open‐label, randomized trial
por: Kaku, Kohei, et al.
Publicado: (2019)

Preserved pharmacokinetics and pharmacodynamics of insulin degludec and liraglutide when administered as insulin degludec/liraglutide in a Chinese population
por: Liu, Hongzhong, et al.
Publicado: (2021)

Insulin Resistance and Type 2 Diabetes
por: Taylor, Roy
Publicado: (2012)

Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes
por: Rodbard, H. W., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p1u04brbk5it0n9dcaqmijk08k